News
Lupin is releasing Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06%, which are the generic of Boehringer ...
Esketamine monotherapy demonstrated beneficial antidepressant effects at multiple doses for patients with treatment-resistant depression, according to results of a phase 4 randomized trial published ...
The Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in a Complete Response Letter (CRL) for etripamil nasal spray (Cardamyst ™ ), an investigational ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. A psychedelic nasal spray requiring a much shorter period of clinical supervision has shown promise against ...
The Food and Drug Administration (FDA) has extended the review period for elinzanetant, an investigational hormone-free therapy for the treatment of moderate to severe vasomotor symptoms (VMS) due to ...
19d
Stocktwits on MSNEvoke Pharma Stock Skyrockets On Patent For Nasal Spray That Eases Stomach Delays; Retail Bulls Pile InEvoke Pharma's stock soared 168% on Wednesday after the company announced it had received a new U.S. patent that could extend the market life of Gimoti, its nasal spray treatment for gastroparesis.
14d
The Brighterside of News on MSNOxytocin nasal spray shows promise for treating alcoholism and obesityOxytocin, often called the “love hormone” for its role in social bonding and maternal behaviors, is now being investigated for something unexpected—its ability to regulate addictive behaviors and ...
One sweltering August night, when the fire alarm went off in their dorm and the air conditioning was broken, two undergrads ...
Find out what you need to know about nasal splints, and discover the pros and cons, risks and benefits, and how they may affect health.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results